Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis

Clinical trial NCT07353671 · RECRUITING

Trial details

NCT number: NCT07353671
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Radiation-induced Dermatitis

Start date: 2026-03-01
Primary completion: 2026-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.